Historical record - last NADAC publication: 1/22/2014
Product Information
ASTHMANEFRIN RFILL 2.25% SOLN is a brand product labeled by Nephron Pharmaceuticals Corporation, priced at $0.7541 per EA under NDC 00487278401. Its NADAC has been published 64 times since Nov 28, 2013.
Strength
11.25 mg/.5mL
Manufacturer
Nephron Pharmaceuticals CorporationNDC
00487278401
Classification
Brand
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Last Updated
1/22/2014
Active Ingredients
RACEPINEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
8/1/2012
Price Statistics
The NADAC for ASTHMANEFRIN RFILL 2.25% SOLN has been published 64 times since Nov 28, 2013, and over the history we have for it it has declined 4.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7541 per EA |
|---|---|
| All-time high | $0.7924 (Jan 15, 2014) |
| All-time low | $0.7541 (Jan 22, 2014) |
| Median price | $0.7541 |
| Average price | $0.7589 |
| Largest weekly change | -4.8% (Jan 22, 2014) |
| Weeks tracked | 64 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the racepinephrine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ASTHMANEFRIN RFILL 2.25% SOLN?
The current National Average Drug Acquisition Cost (NADAC) for ASTHMANEFRIN RFILL 2.25% SOLN, manufactured by Nephron Pharmaceuticals Corporation, is $0.7541 per EA (NDC 00487278401), effective Feb 11, 2015.
How has the price of ASTHMANEFRIN RFILL 2.25% SOLN changed over time?
Over the history we have for it, the NADAC for ASTHMANEFRIN RFILL 2.25% SOLN has declined 4.8%. It has been tracked across 64 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ASTHMANEFRIN RFILL 2.25% SOLN?
Since Nov 28, 2013, the NADAC for ASTHMANEFRIN RFILL 2.25% SOLN has ranged from a low of $0.7541 (Jan 22, 2014) to a high of $0.7924 (Jan 15, 2014), with a median of $0.7541 per EA.
Are there cheaper alternatives to ASTHMANEFRIN RFILL 2.25% SOLN?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ASTHMANEFRIN RFILL 2.25% SOLN, so no direct lower-cost alternative is listed.
Who manufactures ASTHMANEFRIN RFILL 2.25% SOLN?
ASTHMANEFRIN RFILL 2.25% SOLN (NDC 00487278401) is labeled by Nephron Pharmaceuticals Corporation, and CMS classifies it as a brand product.
Related Drugs
Same classification